symbol,name,description,country,year,period,documentUrl,income,expenses,postedName,date,clientId,registrantId,senateId,houseRegistrantId
EYPT,"EYEPOINT PHARMACEUTICALS, INC.",Specialty biopharmaceutical company.,US,2022,Q2,https://lda.senate.gov/filings/public/filing/7bebc4e5-4bea-4fe5-8ffd-f97d0e95415d/print/,80000,,,,205136,400976792,400976792-205136,400976792
EYPT,"EYEPOINT PHARMACEUTICALS, INC.",Specialty biopharmaceutical company.,US,2022,Q3,https://lda.senate.gov/filings/public/filing/52a4bc12-f4a9-43d6-a03f-cded52c76bdf/print/,80000,,,,205136,400976792,400976792-205136,400976792
EYPT,"EYEPOINT PHARMACEUTICALS, INC.",Specialty biopharmaceutical company.,US,2022,Q4,https://lda.senate.gov/filings/public/filing/0029ad1e-2e24-4b98-84db-4ab368fb9625/print/,80000,,,,205136,400976792,400976792-205136,400976792
